JP2018506511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018506511A5 JP2018506511A5 JP2017531626A JP2017531626A JP2018506511A5 JP 2018506511 A5 JP2018506511 A5 JP 2018506511A5 JP 2017531626 A JP2017531626 A JP 2017531626A JP 2017531626 A JP2017531626 A JP 2017531626A JP 2018506511 A5 JP2018506511 A5 JP 2018506511A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- hydrogen
- group
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462091200P | 2014-12-12 | 2014-12-12 | |
| US62/091,200 | 2014-12-12 | ||
| PCT/IB2015/059525 WO2016092508A1 (en) | 2014-12-12 | 2015-12-10 | Treatment of breast cancer brain metastases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018506511A JP2018506511A (ja) | 2018-03-08 |
| JP2018506511A5 true JP2018506511A5 (https=) | 2019-01-24 |
| JP6847835B2 JP6847835B2 (ja) | 2021-03-24 |
Family
ID=55024190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017531626A Expired - Fee Related JP6847835B2 (ja) | 2014-12-12 | 2015-12-10 | 乳がん脳転移の処置 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10689459B2 (https=) |
| EP (1) | EP3229803B1 (https=) |
| JP (1) | JP6847835B2 (https=) |
| CN (1) | CN108367003B (https=) |
| ES (1) | ES2784900T3 (https=) |
| WO (1) | WO2016092508A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110115758B (zh) * | 2018-02-05 | 2021-05-11 | 中山大学 | Pik3ip1蛋白在调节t细胞反应和制备抗肿瘤药物中的应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5374548A (en) | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| MX9203291A (es) | 1985-06-26 | 1992-08-01 | Liposome Co Inc | Metodo para acoplamiento de liposomas. |
| US4880078A (en) | 1987-06-29 | 1989-11-14 | Honda Giken Kogyo Kabushiki Kaisha | Exhaust muffler |
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| US5183884A (en) | 1989-12-01 | 1993-02-02 | United States Of America | Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| CA2109528A1 (en) | 1991-05-01 | 1992-11-02 | Gregory A. Prince | A method for treating infectious respiratory diseases |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US6132764A (en) | 1994-08-05 | 2000-10-17 | Targesome, Inc. | Targeted polymerized liposome diagnostic and treatment agents |
| US6019968A (en) | 1995-04-14 | 2000-02-01 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
| ATE508733T1 (de) | 1996-03-04 | 2011-05-15 | Penn State Res Found | Materialien und verfahren zur steigerung der zellulären internalisierung |
| US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US6056973A (en) | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
| CA2277801C (en) | 1997-01-16 | 2002-10-15 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| WO1999066903A2 (en) | 1998-06-24 | 1999-12-29 | Advanced Inhalation Research, Inc. | Large porous particles emitted from an inhaler |
| WO2004072266A2 (en) | 2003-02-13 | 2004-08-26 | Kalobios Inc. | Antibody affinity engineering by serial epitope-guided complementarity replacement |
| GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
| JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
| EP2205242B1 (en) | 2007-09-12 | 2015-04-15 | Genentech, Inc. | Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use |
| JP5348725B2 (ja) | 2007-10-25 | 2013-11-20 | ジェネンテック， インコーポレイテッド | チエノピリミジン化合物の製造方法 |
| US20110033453A1 (en) * | 2008-03-05 | 2011-02-10 | Carlos Garcia-Echeverria | Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| AU2011290672B2 (en) | 2010-08-20 | 2015-07-09 | Novartis Ag | Antibodies for epidermal growth factor receptor 3 (HER3) |
| EP3590538A1 (en) * | 2011-12-05 | 2020-01-08 | Novartis AG | Antibodies for epidermal growth factor receptor 3 (her3) |
| WO2014028566A1 (en) | 2012-08-16 | 2014-02-20 | Novartis Ag | Combination of pi3k inhibitor and c-met inhibitor |
| WO2014177915A1 (en) | 2013-05-01 | 2014-11-06 | Piramal Enterprises Limited | Cancer combination therapy using imidazo[4,5-c]quinoline derivatives |
| EP3539990B1 (en) | 2014-07-16 | 2021-09-08 | Dana-Farber Cancer Institute, Inc. | Her3 inhibition in low-grade serous cancers |
-
2015
- 2015-12-10 ES ES15816534T patent/ES2784900T3/es active Active
- 2015-12-10 US US15/535,405 patent/US10689459B2/en not_active Expired - Fee Related
- 2015-12-10 WO PCT/IB2015/059525 patent/WO2016092508A1/en not_active Ceased
- 2015-12-10 CN CN201580075191.0A patent/CN108367003B/zh not_active Expired - Fee Related
- 2015-12-10 EP EP15816534.0A patent/EP3229803B1/en active Active
- 2015-12-10 JP JP2017531626A patent/JP6847835B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7507209B6 (ja) | がんを治療するための、ｐｄ－１アンタゴニスト及びｖｅｇｆｒ／ｆｇｆｒ／ｒｅｔチロシンキナーゼ阻害剤の組合せ | |
| KR102349056B1 (ko) | Pd-1 억제제를 투여함으로써 피부암을 치료하는 방법 | |
| Awada et al. | Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy | |
| CN109890387B (zh) | 谷氨酸调节剂与免疫疗法用以治疗癌症的用途 | |
| JP6774421B2 (ja) | がんの治療のための方法、組成物、及びキット | |
| JP2016502504A5 (https=) | ||
| JP2015534579A5 (https=) | ||
| JP2015534577A5 (https=) | ||
| JP2015534580A5 (https=) | ||
| JP2018532803A (ja) | 癌を処置するためのｔｌｒ８アゴニストの使用 | |
| JP2015534578A5 (https=) | ||
| AU2012253858B2 (en) | Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-ErbB3 agents | |
| JP2024513505A (ja) | 腫瘍を治療するための組成物及び方法 | |
| JP2020506945A (ja) | がんの治療のための方法、組成物及びキット | |
| AU2017206108A1 (en) | Combination of a chromene compound and a second active agent | |
| JP2023515675A5 (https=) | ||
| JP2019524714A5 (https=) | ||
| US20220195059A1 (en) | Rank Pathway Inhibitors in Combination with CDK Inhibitors | |
| JP2023510199A5 (https=) | ||
| JP2013542228A (ja) | Ｅｇｆｒ依存性疾患またはｅｇｆｒファミリーメンバーを標的とする薬剤に対して獲得耐性を有する疾患の治療における２−カルボキサミドシクロアミノウレア誘導体の使用 | |
| EP3893888A1 (en) | Combination therapies for treating disease using an innate immunity modifier and an ox40 agonist | |
| JP2018506511A5 (https=) | ||
| JP2024529451A (ja) | がんを治療するための方法及び組成物 | |
| WO2017176565A1 (en) | Combinations of an anti-b7-h1 antibody and a cxcr4 peptide antagonist for treating a solid tumor | |
| WO2023174210A1 (en) | Combination treatment for cancer |